Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Diagnosing liver damage earlier could help to prevent liver failure in many patients.
MISTI Global Seed Funds are open for proposals after Covid pivot.
Fluorescent imaging technique simultaneously captures different signal types from multiple locations in a live cell.
MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.
Professor and mentor for more than 20 years at MIT redefined scientists’ understanding of the biology of cell division and proliferation.
Author Susan Hockfield, MIT president emerita and professor of neuroscience, receives 2020 Science Communication Award.
Unexpected findings in chemokine receptors once believed to be non-functional open up new fields of scientific inquiry.
A search committee chaired by Institute Professor Phillip Sharp will work to identify a new director for MIT’s pioneering cancer research center.
Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells.
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
Using these new particles, researchers could develop treatments for heart disease and other conditions.
MIT researchers find blocking the expression of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.
Molecular biologist and professor emerita advocates for more inclusive science and advises how to get there.
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.